Diverse anti-tumor immune cells, including plasma B cells, CD8+ T cells, activated memory CD4+ T cells, activated natural killer (NK) cells, M1-like macrophages and activated dendritic cells (DCs) were found highly enriched in the low-risk population. This evidence concerns the gene CD8A and neoplasm.